Literature DB >> 12588946

Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies.

David Q-H Wang1, Martin C Carey.   

Abstract

The rate of intestinal cholesterol (Ch) absorption is an important criterion for quantitation of Ch homeostasis. However, studies in the literature suggest that percent Ch absorption, measured usually by a fecal dual-isotope ratio method, spans a wide range, from 20% to 90%, in healthy inbred mice on a chow diet. In the present study, we adapted four standard methods, one direct (lymph collection) and three indirect (plasma and fecal dual-isotope ratio, and sterol balance) measurements of Ch absorption and applied them to mice. Our data establish that all methodologies can be valid in mice, with all methods supporting the concept that gallstone-susceptible C57L mice absorb significantly more Ch (37 +/- 5%) than gallstone-resistant AKR mice (24 +/- 4%). We ascertained that sources of error in the literature leading to marked differences in Ch absorption efficiencies between laboratories relate to a number of technical factors, most notably expertise in mouse surgery, complete solubilization and delivery of radioisotopes, appropriate collection periods for plasma and fecal samples, and total extraction of radioisotopes from feces. We find that all methods provide excellent interexperimental agreement, and the ranges obtained challenge previously held beliefs regarding the spread of intestinal Ch absorption efficiencies in mice. The approaches documented herein provide quantifiable methodologies for exploring genetic mechanisms of Ch absorption, and for investigating the assembly and secretion of chylomicrons, as well as intestinal lipoprotein metabolism in mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588946     DOI: 10.1194/jlr.D200041-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Frank Lammert; Anne Schmitz; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2010-04-28       Impact factor: 4.686

2.  Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.

Authors:  Thomas Pfeifer; Marlene Buchebner; Prakash G Chandak; Jay Patankar; Adelheid Kratzer; Sascha Obrowsky; Gerald N Rechberger; Rajendra S Kadam; Uday B Kompella; Gerhard M Kostner; Dagmar Kratky; Sanja Levak-Frank
Journal:  Curr Pharm Biotechnol       Date:  2011-02-01       Impact factor: 2.837

Review 3.  From blood to gut: direct secretion of cholesterol via transintestinal cholesterol efflux.

Authors:  Carlos L J Vrins
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

4.  The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2016-01-12       Impact factor: 4.686

Review 5.  New insights into the molecular mechanism of intestinal fatty acid absorption.

Authors:  Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-09-18       Impact factor: 4.686

6.  Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters.

Authors:  Christophe Gardès; Evelyne Chaput; Andreas Staempfli; Denise Blum; Hans Richter; G Martin Benson
Journal:  J Lipid Res       Date:  2013-02-21       Impact factor: 5.922

7.  Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.

Authors:  Anne S Henkel; Mark H Kavesh; Michael S Kriss; Amanda M Dewey; Mary E Rinella; Richard M Green
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

8.  Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine.

Authors:  Chang Xie 谢畅; Zhang-Sen Zhou 周章森; Na Li 李钠; Yan Bian 卞艳; Yong-Jian Wang 王永建; Li-Juan Wang 王丽娟; Bo-Liang Li 李伯良; Bao-Liang Song 宋保亮
Journal:  J Lipid Res       Date:  2012-07-17       Impact factor: 5.922

9.  Comparison of the pharmacological profiles of murine antisense oligonucleotides targeting apolipoprotein B and microsomal triglyceride transfer protein.

Authors:  Richard G Lee; Wuxia Fu; Mark J Graham; Adam E Mullick; Donna Sipe; Danielle Gattis; Thomas A Bell; Sheri Booten; Rosanne M Crooke
Journal:  J Lipid Res       Date:  2012-12-06       Impact factor: 5.922

10.  Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis.

Authors:  David Q-H Wang; Frank Schmitz; Alan S Kopin; Martin C Carey
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.